BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Abou Khouzam R, Brodaczewska K, Filipiak A, Zeinelabdin NA, Buart S, Szczylik C, Kieda C, Chouaib S. Tumor Hypoxia Regulates Immune Escape/Invasion: Influence on Angiogenesis and Potential Impact of Hypoxic Biomarkers on Cancer Therapies. Front Immunol 2020;11:613114. [PMID: 33552076 DOI: 10.3389/fimmu.2020.613114] [Cited by in Crossref: 34] [Cited by in F6Publishing: 38] [Article Influence: 17.0] [Reference Citation Analysis]
Number Citing Articles
1 Subramanian M, Kabir AU, Barisas D, Krchma K, Choi K. Conserved angio-immune subtypes of the tumor microenvironment predict response to immune checkpoint blockade therapy. Cell Rep Med 2023;4:100896. [PMID: 36630952 DOI: 10.1016/j.xcrm.2022.100896] [Reference Citation Analysis]
2 Park JH, Lee HK. The Role of Hypoxia in Brain Tumor Immune Responses. Brain Tumor Res Treat 2023;11:39. [DOI: 10.14791/btrt.2022.0043] [Reference Citation Analysis]
3 Mougel A, Méjean F, Tran T, Adimi Y, Galy-fauroux I, Kaboré C, Mercier E, Urquia P, Terme M, Tartour E, Tanchot C. Synergistic effect of combining sunitinib with a peptide-based vaccine in cancer treatment after microenvironment remodeling. OncoImmunology 2022;11:2110218. [DOI: 10.1080/2162402x.2022.2110218] [Reference Citation Analysis]
4 Pugh-toole M, Dawe N, Boudreau JE, Leung BM. Tumor Spheroids Layered in an Imageable Cancer Environment (T-SLICE): a novel in vitro platform to study tumor biology.. [DOI: 10.1101/2022.10.08.511443] [Reference Citation Analysis]
5 Ene CD, Nicolae I. Hypoxia-Nitric Oxide Axis and the Associated Damage Molecular Pattern in Cutaneous Melanoma. J Pers Med 2022;12. [PMID: 36294785 DOI: 10.3390/jpm12101646] [Reference Citation Analysis]
6 McRitchie BR, Akkaya B. Exhaust the exhausters: Targeting regulatory T cells in the tumor microenvironment. Front Immunol 2022;13:940052. [PMID: 36248808 DOI: 10.3389/fimmu.2022.940052] [Reference Citation Analysis]
7 Kawaguchi K, Maeshima Y, Toi M. Tumor immune microenvironment and systemic response in breast cancer. Med Oncol 2022;39:208. [PMID: 36175677 DOI: 10.1007/s12032-022-01782-0] [Reference Citation Analysis]
8 Charlestin V, Fulkerson D, Arias Matus CE, Walker ZT, Carthy K, Littlepage LE. Aquaporins: New players in breast cancer progression and treatment response. Front Oncol 2022;12:988119. [DOI: 10.3389/fonc.2022.988119] [Reference Citation Analysis]
9 Kosim MY, Fukazawa T, Miyauchi M, Hirohashi N, Tanimoto K. p53 status modifies cytotoxic activity of lactoferrin under hypoxic conditions. Front Pharmacol 2022;13:988335. [DOI: 10.3389/fphar.2022.988335] [Reference Citation Analysis]
10 Maimaitiming N, Ma X, Wei Y, Cao L, Gao Y, Zhang L. Efficacy and safety of endostar combined with chemoradiotherapy versus chemoradiotherapy alone in locally advanced cervical cancer: A PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore) 2022;101:e30170. [PMID: 36086700 DOI: 10.1097/MD.0000000000030170] [Reference Citation Analysis]
11 Zhao B, Li X, Kong Y, Wang W, Wen T, Zhang Y, Deng Z, Chen Y, Zheng X. Recent advances in nano-drug delivery systems for synergistic antitumor immunotherapy. Front Bioeng Biotechnol 2022;10:1010724. [DOI: 10.3389/fbioe.2022.1010724] [Reference Citation Analysis]
12 Seliger B, Al-samadi A, Yang B, Salo T, Wickenhauser C. In vitro models as tools for screening treatment options of head and neck cancer. Front Med 2022;9. [DOI: 10.3389/fmed.2022.971726] [Reference Citation Analysis]
13 Najafi A, Keykhaee M, Khorramdelazad H, Karimi MY, Nejatbakhsh Samimi L, Aghamohamadi N, Karimi M, Falak R, Khoobi M. Catalase application in cancer therapy: Simultaneous focusing on hypoxia attenuation and macrophage reprogramming. Biomedicine & Pharmacotherapy 2022;153:113483. [DOI: 10.1016/j.biopha.2022.113483] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Wang S, Xing N, Meng X, Xiang L, Zhang Y. Comprehensive bioinformatics analysis to identify a novel cuproptosis-related prognostic signature and its ceRNA regulatory axis and candidate traditional Chinese medicine active ingredients in lung adenocarcinoma. Front Pharmacol 2022;13:971867. [DOI: 10.3389/fphar.2022.971867] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Hu T, Wang Y, Wang X, Wang R, Song Y, Zhang L, Han S. Construction and validation of an angiogenesis-related gene expression signature associated with clinical outcome and tumor immune microenvironment in glioma. Front Genet 2022;13:934683. [DOI: 10.3389/fgene.2022.934683] [Reference Citation Analysis]
16 Lê H, Seitlinger J, Lindner V, Olland A, Falcoz P, Benkirane-jessel N, Quéméneur E. Patient-Derived Lung Tumoroids—An Emerging Technology in Drug Development and Precision Medicine. Biomedicines 2022;10:1677. [DOI: 10.3390/biomedicines10071677] [Reference Citation Analysis]
17 Zhang L, Yan C, Hou X, Zhang X, Xie J, Xu H, Tong Y, Cui X, Cai K, Pu X, Wang L, Bai T, Wang D. The predictive accuracy of preoperative erythrocyte count and maximum tumor diameter to maximum kidney diameter ratio in renal cell carcinoma. Transl Androl Urol 2022;11:974-81. [PMID: 35958894 DOI: 10.21037/tau-22-414] [Reference Citation Analysis]
18 Smolanka II, Bagmut IY, Sheremet MI, Movchan OV, Oleksandrovich LA, Smolanka II Jr, Leonidovich KI, Lazaruk OV, Maksymyuk VV, Tarabanchuk VV. Phosphorus metabolism disorders in erythrocytes and lymphocytes among patients with inflammatory breast cancer, infiltrative stomach and colorectal cancer. J Med Life 2022;15:747-50. [PMID: 35928359 DOI: 10.25122/jml-2022-0048] [Reference Citation Analysis]
19 Filipiak-Duliban A, Brodaczewska K, Majewska A, Kieda C. Spheroid culture models adequately imitate distinctive features of the renal cancer or melanoma microenvironment. In Vitro Cell Dev Biol Anim 2022;58:349-64. [PMID: 35536385 DOI: 10.1007/s11626-022-00685-8] [Reference Citation Analysis]
20 Holbert CE, Cullen MT, Casero RA Jr, Stewart TM. Polyamines in cancer: integrating organismal metabolism and antitumour immunity. Nat Rev Cancer 2022. [PMID: 35477776 DOI: 10.1038/s41568-022-00473-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
21 Ljoki A, Aslam T, Friis T, Ohm RG, Houen G. In Vitro Angiogenesis Inhibition and Endothelial Cell Growth and Morphology. Int J Mol Sci 2022;23:4277. [PMID: 35457095 DOI: 10.3390/ijms23084277] [Reference Citation Analysis]
22 Sharma A, Sinha S, Shrivastava N. Therapeutic Targeting Hypoxia-Inducible Factor (HIF-1) in Cancer: Cutting Gordian Knot of Cancer Cell Metabolism. Front Genet 2022;13:849040. [DOI: 10.3389/fgene.2022.849040] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 11.0] [Reference Citation Analysis]
23 Abou Khouzam R, Zaarour RF, Brodaczewska K, Azakir B, Venkatesh GH, Thiery J, Terry S, Chouaib S. The Effect of Hypoxia and Hypoxia-Associated Pathways in the Regulation of Antitumor Response: Friends or Foes? Front Immunol 2022;13:828875. [PMID: 35211123 DOI: 10.3389/fimmu.2022.828875] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
24 Park JH, Lee HK. Current Understanding of Hypoxia in Glioblastoma Multiforme and Its Response to Immunotherapy. Cancers (Basel) 2022;14:1176. [PMID: 35267480 DOI: 10.3390/cancers14051176] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
25 Zhang Q, Pan J, Nie H, Wang H, An F, Zhan Q. Dishevelled-Associated Activator of Morphogenesis 2 (DAAM2) Predicts the Immuno-Hot Phenotype in Pancreatic Adenocarcinoma. Front Mol Biosci 2022;9:750083. [DOI: 10.3389/fmolb.2022.750083] [Reference Citation Analysis]
26 Liu D, Hu Z, Jiang J, Zhang J, Hu C, Huang J, Wei Q. Five hypoxia and immunity related genes as potential biomarkers for the prognosis of osteosarcoma. Sci Rep 2022;12. [DOI: 10.1038/s41598-022-05103-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Mortezaee K, Majidpoor J. (Im)maturity in Tumor Ecosystem. Front Oncol 2022;11:813897. [DOI: 10.3389/fonc.2021.813897] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 13.0] [Reference Citation Analysis]
28 Lappano R, Todd LA, Stanic M, Cai Q, Maggiolini M, Marincola F, Pietrobon V. Multifaceted Interplay between Hormones, Growth Factors and Hypoxia in the Tumor Microenvironment. Cancers 2022;14:539. [DOI: 10.3390/cancers14030539] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
29 Zheng Z, Bian C, Wang H, Su J, Meng L, Xin Y, Jiang X. Prediction of immunotherapy efficacy and immunomodulatory role of hypoxia in colorectal cancer. Ther Adv Med Oncol 2022;14:175883592211383. [DOI: 10.1177/17588359221138383] [Reference Citation Analysis]
30 El-Benhawy SA, Sakr OA, Fahmy EI, Ali RA, Hussein MS, Nassar EM, Salem SM, Abu-Samra N, Elzawawy S. Assessment of Serum Hypoxia Biomarkers Pre- and Post-radiotherapy in Patients with Brain Tumors. J Mol Neurosci 2022;72:2303-12. [PMID: 36121548 DOI: 10.1007/s12031-022-02065-z] [Reference Citation Analysis]
31 Huang M, Lei Y, Zhong Y, Chung C, Wang M, Hu M, Deng L. New Insights Into the Regulatory Roles of Extracellular Vesicles in Tumor Angiogenesis and Their Clinical Implications. Front Cell Dev Biol 2021;9:791882. [PMID: 34966744 DOI: 10.3389/fcell.2021.791882] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
32 Hassan Venkatesh G, Abou Khouzam R, Shaaban Moustafa Elsayed W, Ahmed Zeinelabdin N, Terry S, Chouaib S. Tumor hypoxia: an important regulator of tumor progression or a potential modulator of tumor immunogenicity? Oncoimmunology 2021;10:1974233. [PMID: 34595058 DOI: 10.1080/2162402X.2021.1974233] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
33 Matuszewska K, Pereira M, Petrik D, Lawler J, Petrik J. Normalizing Tumor Vasculature to Reduce Hypoxia, Enhance Perfusion, and Optimize Therapy Uptake. Cancers (Basel) 2021;13:4444. [PMID: 34503254 DOI: 10.3390/cancers13174444] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 6.5] [Reference Citation Analysis]
34 Ngo-huang A, Fricke BC, Schadler KL, Parker NH. Preliminary Evidence on the Effects of Exercise on Tumor Biology: a Potential Guide for Prescribing Exercise. Curr Phys Med Rehabil Rep 2021;9:136-41. [DOI: 10.1007/s40141-021-00316-5] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
35 Anduran E, Dubois LJ, Lambin P, Winum JY. Hypoxia-activated prodrug derivatives of anti-cancer drugs: a patent review 2006 - 2021. Expert Opin Ther Pat 2021;:1-12. [PMID: 34241566 DOI: 10.1080/13543776.2021.1954617] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
36 Huang CH, Chong KY, Lei KF. Analysis of the Internal Hypoxic Environment in Solid Tumor Tissue Using a Folding Paper System. ACS Appl Mater Interfaces 2021;13:33885-93. [PMID: 34259499 DOI: 10.1021/acsami.1c08857] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
37 Bannoud N, Dalotto-Moreno T, Kindgard L, García PA, Blidner AG, Mariño KV, Rabinovich GA, Croci DO. Hypoxia Supports Differentiation of Terminally Exhausted CD8 T Cells. Front Immunol 2021;12:660944. [PMID: 34025660 DOI: 10.3389/fimmu.2021.660944] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
38 Lampis A, Ratti M, Ghidini M, Mirchev MB, Okuducu AF, Valeri N, Hahne JC. Challenges and perspectives for immunotherapy in oesophageal cancer: A look to the future (Review). Int J Mol Med 2021;47:97. [PMID: 33846775 DOI: 10.3892/ijmm.2021.4930] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]